CClinicalTrials.gg
Status unknownNCT03456765Updated Jan 10, 2019

Fetal Kidney in Estimation of GA in Pregnancy

An observational study in Gestational Age and Maturity, sponsored by Aljazeera Hospital. Status unknown at 1 site in Egypt. Open to female participants aged 18 Years to 42 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-01-10.

Sponsored by Aljazeera Hospital · Observational

The sponsor has not verified this record recently (last verified Jan 2019), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
350
Ages
18 Years to 42 Years
Sex
Female
01

Study summary

A true estimation of gestational age (GA) plays animportant role in quality of maternity care such asassessment of fetal growth and to schedule the labordate. Any inaccurate estimation may lead to peri-natalmorbidity and mortality due to iatrogenic pre- or post-maturity .

Read the detailed description

Several longitudinal studies have been performed in the western countries concerning sonographic measurement of fetal kidney length. Initially these were done for diagnosis of renal malformation in utero \& later on they were to find out the correlation between the fetal kidney length and the gestational age

02

Conditions studied

  • Gestational Age and Maturity
03

Who can participate

Ages eligible
18 Years to 42 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

pregnant ladies with no medical disorders with pregnancy between 16 weeks and 40 weeks in a single living fetus

Inclusion criteria

  1. Single fetus.
  2. pregnant ladies. with no medical disorders
  3. Fetal kidneys are normally seen

Exclusion criteria

Exclusion Criteria:

  • Medical disorders with pregnancy
  • Renal anomalies
  • Renal agesnesis
04

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
350 participants (estimated)
Target follow-up
2 Months
Patient registry
Yes

Interventions

  • Diagnostic testUltrasound

    US will be made to assess kidneys

05

What researchers measure

Primary outcomes

  1. The number of participants who will have accurate GA calculated by Kidney parameters

    describes the efficiency of kidney parameters to estimate GA

    Time frame: within 2 months

06

Study locations

1 of 1 sites recruiting
  • Algazeerah
    Giza, Egypt
    • Mahmoud Alalfy, master · Contact · mahmoudalalfy@ymail.com · +201002611058
    • Ahmed Elgazzar, M.D · Contact · +201014005959
    • Mahmoud Alalfy, master · Principal investigator
    Recruiting
07

Registry details

Key details

Study ID
NCT03456765
Lead sponsor
Aljazeera Hospital
Collaborators
Kasr El Aini Hospital, National Research Centre, Egypt
Responsible party
Mahmoud Alalfy (Assistant Researcher , National Research centre and Specialist of Obstetrics and Gynecology in Aljazeerah hospital, Aljazeera Hospital) — Principal investigator
First posted
Mar 7, 2018
Start date
Mar 12, 2018
Primary completion
Apr 15, 2019 (estimated)
Completion
Apr 20, 2019 (estimated)
Last update
Jan 10, 2019

Study contacts

Mahmoud Alalfy
Contact
mahmoudalalfy@ymail.com
01002611058
Mahmoud Alalfy
principal investigator · Algazeerah hospital -Location (Giza -Egypt ) and National Research centre egypt

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion